Title : Efficacy and safety of iguratimod on patients with primary Sjögren's syndrome: a randomized, placebo-controlled clinical trial.

Pub. Date : 2021 Mar

PMID : 33118847






1 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 Conclusion: Iguratimod improved some dryness symptoms and disease activity in pSS patients, and reduced the level of BAFF and percentage of plasma cells over 24 weeks. iguratimod TNF superfamily member 13b Homo sapiens